NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Raydiant Oximetry

Raydiant Oximetry

Private
San Ramon, CaliforniaHealthcare & Life Scienceshttps://raydiantoximetry.com/

Last Round

Grant

Nov 1, 2024

Total Funding Raised

$30.45M

Company Overview

Raydiant Oximetry is a medical technology company that develops non-invasive fetal pulse oximetry sensors to monitor fetal oxygen levels during labor and delivery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

fetal pulse oximetryfetal monitoringmaternal healthfetal oxygen saturationnon-invasive monitoringlabor and deliverymedical devicefetal distressbiophotonicsinvestigational device exemptionIDEob-gyn techfemtechclinical trialssignal processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Raydiant Oximetry Comps

Public and private peers based on sector, stage, and business model.

Raydiant Oximetry comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Raydiant Oximetry Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2024
GrantSep 24, 2024
Series A ExtensionJun 4, 2024
Series BFeb 7, 2023
Series A ExtensionNov 2, 2021
Grant
May 26, 2021

Key People

Founding team and executive leadership

Michael Nagel

Chief Executive Officer

Executive Team

Neil Ray

CEO Founder

Founding Team

Russ DeLonzor

President And Chief Operating Officer

Executive Team

Raydiant Oximetry Investors

Notable investors and investment history

Raydiant Oximetry investors
InvestorRounds
National Institute of Biomedical Imaging and BioengineeringGrant
KOFA HealthcareSeries A Extension
March of DimesSeries B, Series A Extension
SteelSky VenturesSeries A Extension
Avestria VenturesSeries A, Series A Extension
Gates FoundationGrant
Tara Health FoundationSeries A Extension

Raydiant Oximetry Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Raydiant Oximetry Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Raydiant Oximetry's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Ramon, California
Employee Range25
Year Founded2017
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.